Cochrane Evidence Synthesis and Methods ►

Glucose-6-phosphate dehydrogenase deficiency near-patient tests for tafenoquine or primaquine use with Plasmodium vivax malaria

This is a protocol for a Cochrane Review (diagnostic). The objectives are as follows:

To assess the diagnostic accuracy of near-patient tests for G6PD deficiency in people undergoing treatment or prophylaxis with primaquine or tafenoquine for malaria; or in people at risk of or susceptible to malaria.

This is a protocol.

Published:

26 January 2021

Authors:

Weeratunga P, Bancone G, Ochodo EA, Pant S, Thapa J, Chaplin M

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Weeratunga P, Bancone G, Ochodo EA, Pant S, Thapa J, Chaplin M. Glucose-6-phosphate dehydrogenase deficiency near-patient tests for tafenoquine or primaquine use with Plasmodium vivax malaria (Protocol). Cochrane Database of Systematic Reviews 2021, Issue 1. Art. No.: CD013861. DOI: 10.1002/14651858.CD013861.